FDA Inspection 965283 — Blood Bank of Alaska, Inc.

Blood Bank of Alaska, Inc. — FEI 3071403

The FDA completed an inspection of Blood Bank of Alaska, Inc. on March 11, 2016 in Anchorage, AK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 11, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Anchorage, AK (United States)

Citations

IDCFRDescription
1220321 CFR 606.170(a)Adverse Reaction- Reports of Investigations
15521 CFR 606.160(b)Required records
5721 CFR 606.60(a)Maintain and clean equipment
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
9821 CFR 606.100(c)Thorough investigations